Sucheta De

Immuno-oncology & Virology

Oncolytic VirusesImmuno-oncologySignal TransductionCell Fate

Ph.D. candidate in Immuno-oncology and Virology focused on how signal transduction networks steer the fate of cancer cells during oncolytic virus infection. My work integrates virology, cell biology, and therapeutic context to map the molecular decisions that enable viral oncolysis, stress responses, and anti-tumor effects. I aim to translate these mechanistic insights into strategies that improve oncolytic virotherapy and immuno-oncology outcomes.

Portrait of Sucheta De

Current Focus

Oncolytic virusโ€“cancer interactions

Nationality

India ๐Ÿ‡ฎ๐Ÿ‡ณ

Education

Academic foundations across biotechnology and immuno-oncology.

Ph.D. in Immuno-oncology and Virology (in progress)

Tel Aviv University

2019 โ€“ 2026 (expected)

Tel Aviv, Israel ๐Ÿ‡ฎ๐Ÿ‡ฑ

Research Experience

Translational virology, immunology, and oncolytic virotherapy.

Oct 2019 โ€“ Feb 2026

Research Scholar

Tel Aviv University

Tel Aviv, Israel ๐Ÿ‡ฎ๐Ÿ‡ฑ

  • Supervisor: Prof. Marcelo Ehrlich
  • Thesis title: Signal transduction crossroads as fate determinants of the interactions of oncolytic viruses and cancer cells

Selected Publications

Peer-reviewed work in oncolytic virotherapy and cell fate biology.

Journal Article

cJun-N-terminal kinase activity and mitosis perturbation drive the 2-methoxyestradiol-mediated enhancement of viral oncolysis by Epizootic Hemorrhagic Disease Virus-Tel Aviv University

S. De, S. Kashkash, V. Bozhdansky, E. Bacharach, and M. Ehrlich

Scientific Reports, 2025

Impact Factor: 3.9 (2024)doi:10.1038/s41598-025-08687-8

Book Chapter

Nuclear Morphology-Based Assessment of Cell Fates Induced by a Microtubule Targeting Agent as a Single Treatment or Combined with an Oncolytic Virus

S. De and M. Ehrlich

Methods in Molecular Biology, Springer Nature, 2025

doi:10.1007/978-1-0716-4542-0_8

Skills

Laboratory, analytical, and scientific communication expertise.

Immunology & Virology

  • Flow cytometry, immunocytochemistry
  • Virus propagation and infection
  • Plaque and neutralization assays
  • Handling patient serum samples for immunological assays
  • BSL-2 handling of viruses
    โ€ข EHDV-TAU, VSV-DM51, HSV-1, JEV
    โ€ข Additional: Dengue (DenV1โ€“4), RSV, rotavirus, WNV

Molecular Biology

  • Western blotting, RT-PCR, cloning, transfection
  • Agarose gel electrophoresis, SDS-PAGE

Cell Culture & In Vivo Models

  • Mammalian cell maintenance
  • Cell-based assays
  • Tumour and oncolytic virotherapy models (syngeneic melanoma, prostate cancer xenografts)

Imaging & Analysis

  • Epifluorescence and confocal microscopy
  • Data organisation and statistical analysis
  • Basic bioinformatics

Scientific Communication

  • Scientific writing, presentation, and documentation

Academic Engagements

Conference presentations and scholarly visibility.

9โ€“11 Oct 2024

30th European Cell Death Organisation Conference

Belval, Luxembourg ๐Ÿ‡ฑ๐Ÿ‡บ

Poster

20 May 2024

2nd Retreat of Shmunis School of Biomedicine and Cancer Research

Tel Aviv-Yafo, Israel ๐Ÿ‡ฎ๐Ÿ‡ฑ

Flash Talk and Poster

28 Jul 2022

1st Retreat of Shmunis School of Biomedicine and Cancer Research

Tel Aviv-Yafo, Israel ๐Ÿ‡ฎ๐Ÿ‡ฑ

Poster

Grants & Funding

Competitive awards supporting doctoral training and travel.

2024

Shmunis Travel Grant and Tel Aviv University Travel Grant

Conference travel support

2019โ€“2024

S Daniel Abraham Institute for Molecular Virology

Tel Aviv University funding for doctoral education

2022โ€“2023

Shmunis Excellence Scholarship

Awarded in 2022 and 2023

2019

TATA Trustโ€“Tel Aviv University PhD Scholarship

Funding for doctoral education following a competitive open call

Trainings & Certifications

Specialized training for animal research and biosafety handling.

01 Mar 2020

Trained and certified for BSL2+ containment